Surrozen (SRZN) Short-term Investments (2020 - 2023)
Surrozen (SRZN) recorded quarterly Short-term Investments of $9.5 million in Q3 2023, down 44.04% quarter-over-quarter from $16.9 million in Q2 2023, and down 82.11% on a YoY basis from $52.9 million in Q3 2022.
Surrozen (SRZN) Short-term Investments (2020 - 2023) Analysis & Trends
Surrozen's Short-term Investments history runs 4 years deep, the most recent figure standing at $9.5 million for Q3 2023.
- In Q3 2023, Short-term Investments fell 82.11% year-over-year to $9.5 million; the TTM figure through Sep 2023 stood at $9.5 million (down 82.11% YoY), while the FY2022 annual figure was $51.1 million, down 25.61% from the prior year.
- Short-term Investments was $9.5 million for Q3 2023 at Surrozen, down from $16.9 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $78.2 million in Q1 2022 to a low of $9.5 million in Q3 2023.
- Historically, Short-term Investments has averaged $45.0 million across 4 years, with a median of $50.1 million in 2021.
- The sharpest annual moves came in 2021 and 2023: Short-term Investments soared 384.23% in 2021, then plunged 82.11% in 2023.
- A 4-year view of Short-term Investments shows it stood at $14.2 million in 2020, then soared by 384.23% to $68.8 million in 2021, then declined by 25.61% to $51.1 million in 2022, then sank by 81.51% to $9.5 million in 2023.
- The last three Short-term Investments figures came in at $9.5 million (Q3 2023), $16.9 million (Q2 2023), and $33.9 million (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 9.46 Mn |
| Jun 30, 2023 | 16.90 Mn |
| Mar 31, 2023 | 33.94 Mn |
| Dec 31, 2022 | 51.15 Mn |
| Sep 30, 2022 | 52.86 Mn |
| Jun 30, 2022 | 75.82 Mn |
| Mar 31, 2022 | 78.21 Mn |
| Dec 31, 2021 | 68.76 Mn |
| Sep 30, 2021 | 49.07 Mn |
| Dec 31, 2020 | 14.20 Mn |